AI-generated summary
In this mouse study, the authors examined whether near-infrared light therapy at 850 nm affected age-related heart changes in mice with accelerated cardiac aging. They report reduced left ventricular mass, improved ejection fraction, reduced aortic stiffness, better gait symmetry and higher cumulative survival in treated AC8 mice compared with untreated controls, with serum TGF-β1 increased. The study used only 8 mice per group.
- Who or what was studied
- Fourteen-month-old AC8 overexpressing transgenic mice and wild-type littermates, 8 per group, in an experimental animal model.
- Wavelengths
- 850 nm
- Limits stated in the abstract
- The study used a small animal sample with mice only, and the authors state that future controlled human studies are required before clinical translation.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 850 nm
- Energy density (fluence)
- 3 J/cm2
- Power density (irradiance)
- 25 mW/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Dose, Near-infrared, Longevity, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.